BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, Kanwal F. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology 2014;60:1871-8. [PMID: 25065513 DOI: 10.1002/hep.27337] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Duan J, Deng M, Xiang Z, Hu J, Qu C, Zhu T, Xu M, Chen J, Xie J, Xie D, Cai M, Li M, Liang H. Impact of WTAP in small HCC and paired adjacent non-neoplastic liver tissue on recurrence: A cohort study with external extension analysis. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.973548] [Reference Citation Analysis]
2 Liu CJ, Chen PJ. Changing epidemiology of liver disease in Asia: Dual infection of HBV and HCV. Liver Int 2022;42:1945-54. [PMID: 34402183 DOI: 10.1111/liv.15040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Chang L, Chang H, Chen P, Chen C, Tsai K, Yean K, Yang H, Chen T, Yu P, Chou C, Chen S. Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan. Medicina 2022;58:521. [DOI: 10.3390/medicina58040521] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Myers L, Mitra A, Ahn J. Addressing Hepatitis B in the Context of Hepatitis C. Curr Hepatology Rep 2021;20:175-182. [DOI: 10.1007/s11901-021-00578-6] [Reference Citation Analysis]
5 Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2021;15:1295-307. [PMID: 34624198 DOI: 10.1080/17474124.2021.1991792] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
6 Iliescu L. Hepatocellular Carcinoma and Antiviral Therapies in HCV Chronic Infection. Advances in Hepatology 2021. [DOI: 10.5772/intechopen.96551] [Reference Citation Analysis]
7 Innocent-adiele HC, Michael BBT, Okonko IO, Ogbu O. SEROPREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG HIV INFECTED INDIVIDUALS IN UYO, AKWA IBOM STATE, NIGERIA.. [DOI: 10.1101/2021.03.06.21253060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Balagopal A, Thio CL. When viruses collide: hepatitis B virus reactivation after hepatitis C treatment. J Clin Invest 2020;130:2823-6. [PMID: 32420916 DOI: 10.1172/JCI137477] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lim EJ, Torresi J. Prevention of Hepatitis C Virus Infection and Liver Cancer. Recent Results Cancer Res 2021;217:107-40. [PMID: 33200364 DOI: 10.1007/978-3-030-57362-1_6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Al-busafi SA, Alnaamani K. Hepatitis C-Induced Hepatocellular Carcinoma in the Middle East. Liver Cancer in the Middle East 2021. [DOI: 10.1007/978-3-030-78737-0_17] [Reference Citation Analysis]
11 Vandana S, R VS. OCCURRENCE OF HEPATITIS B AND HEPATITIS C AND THEIR DUAL INFECTIONS: A GREAT PUBLIC HEALTH CONCERN. IJAR 2020. [DOI: 10.36106/ijar/1001582] [Reference Citation Analysis]
12 Khatun M, Ray R, Ray RB. Hepatitis C virus associated hepatocellular carcinoma. Adv Cancer Res 2021;149:103-42. [PMID: 33579422 DOI: 10.1016/bs.acr.2020.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Kruse RL, Legras X, Barzi M. Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection. Virus Res 2021;292:198224. [PMID: 33166564 DOI: 10.1016/j.virusres.2020.198224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Kanwal F, Taylor TJ, Kramer JR, Cao Y, Smith D, Gifford AL, El-Serag HB, Naik AD, Asch SM. Development, Validation, and Evaluation of a Simple Machine Learning Model to Predict Cirrhosis Mortality. JAMA Netw Open 2020;3:e2023780. [PMID: 33141161 DOI: 10.1001/jamanetworkopen.2020.23780] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
15 El-Meguid MA, Dawood RM, Ibrahim MK, Salum GM, Ahmed Abd Alla MD, El Awady MK. Reactivation of human cytomegalovirus inhibits expression of liver fibrosis related cytokines in patients chronically infected with hepatitis C virus genotype 4a. Microb Pathog 2021;152:104596. [PMID: 33127535 DOI: 10.1016/j.micpath.2020.104596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Owusu DO, Owusu M, Owusu BA. Human defensins and Th-1 cytokines in hepatitis C viral infection. Pan Afr Med J 2020;37:103. [PMID: 33425136 DOI: 10.11604/pamj.2020.37.103.25211] [Reference Citation Analysis]
17 Kruse RL, Legras X, Barzi M. Cre/LoxP-HBV plasmids generating recombinant covalently closed circular DNA genome upon transfection.. [DOI: 10.1101/2020.07.21.214171] [Reference Citation Analysis]
18 Dash S, Aydin Y, Widmer KE, Nayak L. Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment. J Hepatocell Carcinoma 2020;7:45-76. [PMID: 32346535 DOI: 10.2147/JHC.S221187] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
19 Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev. 2020;33. [PMID: 32102898 DOI: 10.1128/cmr.00046-19] [Cited by in Crossref: 100] [Cited by in F6Publishing: 106] [Article Influence: 50.0] [Reference Citation Analysis]
20 Ghany MG, Morgan TR; AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology 2020;71:686-721. [PMID: 31816111 DOI: 10.1002/hep.31060] [Cited by in Crossref: 314] [Cited by in F6Publishing: 278] [Article Influence: 157.0] [Reference Citation Analysis]
21 Sagnelli E, Macera M, Russo A, Coppola N, Sagnelli C. Epidemiological and etiological variations in hepatocellular carcinoma. Infection. 2020;48:7-17. [PMID: 31347138 DOI: 10.1007/s15010-019-01345-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 24.3] [Reference Citation Analysis]
22 Whitsett M, Feldman DM, Pan CQ. Risk assessment and management of hepatitis B reactivation from direct-acting antivirals for hepatitis C. Liver Research 2019;3:75-79. [DOI: 10.1016/j.livres.2019.03.002] [Reference Citation Analysis]
23 Harris AM, Millman AJ, Lora M, Osinubi A, Lom J, Miller LS. Hepatitis B testing, care linkage, and vaccination coverage within a registry of hepatitis C infected patients. Vaccine 2019;37:2188-93. [PMID: 30902481 DOI: 10.1016/j.vaccine.2019.03.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ning Q, Wu T, Su H, Ma K, Qi J, Ni M, Wu D. Antiviral Therapy for AECHB and Severe Hepatitis B (Liver Failure). Acute Exacerbation of Chronic Hepatitis B 2019. [DOI: 10.1007/978-94-024-1603-9_5] [Reference Citation Analysis]
25 Garren P, Serper M. Chronic Hepatitis B in US Veterans. Curr Hepatol Rep 2019;18:310-5. [PMID: 33134031 DOI: 10.1007/s11901-019-00479-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Bixler D, Zhong Y, Ly KN, Moorman AC, Spradling PR, Teshale EH, Rupp LB, Gordon SC, Boscarino JA, Schmidt MA, Daida YG, Holmberg SD, Holmberg SD, Teshale EH, Spradling PR, Moorman AC, Xing J, Zhong Y, Gordon SC, Nerenz DR, Lu M, Lamerato L, Li J, Rupp LB, Akkerman N, Zhang T, Trudeau S, Zhou Y, Wu K, Boscarino JA, Daar ZS, Smith RE, Daida YG, Trinacty CM, Lai JW, Wong CP, Schmidt MA, Donald JL; CHeCS Investigators. Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS). Clinical Infectious Diseases 2019;68:956-63. [DOI: 10.1093/cid/ciy598] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
27 Yeh ML, Huang CI, Huang CF, Hsieh MH, Hsieh MY, Lin ZY, Chen SC, Huang JF, Kuo PL, Kuo HT, Dai CY, Yu ML, Chuang WL. Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C. Oncotarget 2018;9:12240-9. [PMID: 29552306 DOI: 10.18632/oncotarget.24219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Axley P, Ahmed Z, Ravi S, Singal AK. Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review. J Clin Transl Hepatol. 2018;6:79-84. [PMID: 29607308 DOI: 10.14218/jcth.2017.00067] [Cited by in Crossref: 66] [Cited by in F6Publishing: 79] [Article Influence: 13.2] [Reference Citation Analysis]
29 Marot A, Belaid A, Orlent H, Sersté T, Michielsen P, Colle I, Laleman W, de Galocsy C, Reynaert H, D'Heygere F, Moreno C, Doerig C, Henrion J, Deltenre P. Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients. Clin Res Hepatol Gastroenterol 2017;41:656-63. [PMID: 28867077 DOI: 10.1016/j.clinre.2017.05.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
30 Aggeletopoulou I, Konstantakis C, Manolakopoulos S, Triantos C. Risk of hepatitis B reactivation in patients treated with direct-acting antivirals for hepatitis C. World J Gastroenterol 2017;23:4317-23. [PMID: 28706414 DOI: 10.3748/wjg.v23.i24.4317] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
31 Lau KCK, Shaheen AA, Aspinall AA, Ricento Ba T, Qureshi Mba K, Congly SE, Borman MA, Jayakumar S, Eksteen B, Lee SS, Stinton L, Swain MG, Burak KW, Coffin CS. Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study. CMAJ Open 2017;5:E431-6. [PMID: 28596186 DOI: 10.9778/cmajo.20170002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: Epidemiology, etiology, and carcinogenesis. J Carcinog 2017;16:1. [PMID: 28694740 DOI: 10.4103/jcar.JCar_9_16] [Cited by in Crossref: 413] [Cited by in F6Publishing: 471] [Article Influence: 82.6] [Reference Citation Analysis]
33 Zhou D, Wang Y, Chen L, Jia L, Yuan J, Sun M, Zhang W, Wang P, Zuo J, Xu Z, Luan J. Evolving roles of circadian rhythms in liver homeostasis and pathology. Oncotarget 2016;7:8625-39. [PMID: 26843619 DOI: 10.18632/oncotarget.7065] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
34 Cho J, Lee SS, Choi YS, Jeon Y, Chung JW, Baeg JY, Si WK, Jang ES, Kim JW, Jeong SH. Occult hepatitis B virus infection is not associated with disease progression of chronic hepatitis C virus infection. World J Gastroenterol 2016; 22(42): 9427-9436 [PMID: 27895431 DOI: 10.3748/wjg.v22.i42.9427] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
35 Kamstra R, Azoulay L, Steele R, Klein MB, Greenaway C. Hospitalizations in Immigrants and Nonimmigrants Diagnosed With Chronic Hepatitis C Infection in Québec. Clin Infect Dis 2016;63:1439-48. [PMID: 27501843 DOI: 10.1093/cid/ciw540] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
36 von Wulffen M, Clark PJ, Macdonald GA, Raj AS, Kendall BJ, Powell EE, Jones MP, Holtmann G. Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability. Aliment Pharmacol Ther 2016;44:68-77. [PMID: 27189900 DOI: 10.1111/apt.13657] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
37 Krishnamurthy P, Hazratjee N, Opris D, Agrawal S, Markert R. Is exposure to Agent Orange a risk factor for hepatocellular cancer?-A single-center retrospective study in the U.S. veteran population. J Gastrointest Oncol 2016;7:426-32. [PMID: 27284476 DOI: 10.21037/jgo.2016.01.09] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
38 Huang YT, Freeman JR, Yang HI, Liu J, Lee MH, Chen CJ. Mediation effect of hepatitis B and C on mortality. Eur J Epidemiol 2016;31:625-33. [PMID: 26792787 DOI: 10.1007/s10654-016-0118-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Bhakya S, Muthukrishnan S, Sukumaran M, Grijalva M, Cumbal L, Franklin Benjamin JH, Senthil Kumar T, Rao MV. Antimicrobial, antioxidant and anticancer activity of biogenic silver nanoparticles – an experimental report. RSC Adv 2016;6:81436-46. [DOI: 10.1039/c6ra17569d] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.8] [Reference Citation Analysis]
40 O'Leary TJ, Dominitz JA, Chang KM. Veterans Affairs Office of Research and Development: Research Programs and Emerging Opportunities in Digestive Diseases Research. Gastroenterology 2015;149:1652-61. [PMID: 26526712 DOI: 10.1053/j.gastro.2015.10.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
41 Collins JM, Raphael KL, Terry C, Cartwright EJ, Pillai A, Anania FA, Farley MM. Hepatitis B Virus Reactivation During Successful Treatment of Hepatitis C Virus With Sofosbuvir and Simeprevir. Clin Infect Dis. 2015;61:1304-1306. [PMID: 26082511 DOI: 10.1093/cid/civ474] [Cited by in Crossref: 134] [Cited by in F6Publishing: 139] [Article Influence: 19.1] [Reference Citation Analysis]
42 Grewal US, Walia G, Bakshi R, Chopra S. Hepatitis B and C Viruses, Their Coinfection and Correlations in Chronic Liver Disease Patients: A Tertiary Care Hospital Study. Int J Appl Basic Med Res 2018;8:204-9. [PMID: 30598905 DOI: 10.4103/ijabmr.IJABMR_338_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Reference Citation Analysis]